" class="no-js "lang="en-US"> Hesham Abdullah - Medtech Alert
Thursday, November 07, 2024
Hesham Abdullah

Hesham Abdullah

About Hesham Abdullah

Related Story

Zejula (Niraparib) Shows Durable and Sustained Long-term Progression-free Survival Benefit in the Prima Study of First-line Platinum-responsive Advanced Ovarian Cancer

September 12 2022

GSK plc (LSE/NYSE: GSK) today announced long-term data from the phase III PRIMA (ENGOT-OV26/GOG-3012) study […]